Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chunkang Xuezhi
- Development stage
- Unknown
- Lead developer
- Inner Mongolia Otokqi Mongolian Pharmaceutical
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Chunkang Xuezhi is a traditional Mongolian medicine developed by Inner Mongolia Aoteqi Mongolian Medicine Co., Ltd. for the treatment of primary hyperlipidemia. As a multi-component herbal formulation, it is designed to regulate lipid metabolism and improve blood circulation. Clinical studies have demonstrated its efficacy in reducing levels of total cholesterol (TC), triglycerides (TG), and low-density lipoprotein cholesterol (LDL-C) in patients with dyslipidemia. The formulation typically includes herbal extracts such as Sea buckthorn (*Hippophae rhamnoides*), which are rich in flavonoids and other bioactive compounds known to modulate lipid pathways. It is administered orally, usually in capsule form, and is marketed in China as a regulated pharmaceutical product for managing blood lipid levels.
- Brand names
- Chunkang Xuezhi
- Other names
- 春康血脂Chunkang Xuezhi Capsules
02
Targets
PPARA (Peroxisome proliferator-activated receptor alpha)HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)
Beyond the preview
Go deeper on Chunkang Xuezhi.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Chunkang Xuezhi.